@inproceedings{inproceedings, title  = {{Phase II study of bortezomib with cisplatin as first-line treatment of malignant pleural mesothelioma (MPM): EORTC 08052}},

 url = {{}},

 year = {{2012}},

 month = {{5}},

 author = {{O'Brien M and Gaafar RM and Popat S and Grossi F and Price A and Talbot DC and Cufer T and Ottensmeier CHH and Danson S and Pallis AG and Hasan B et al}},

 volume = {{30}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{15}},

 note = {{Accessed on 2025/01/03}}}